English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Monday, May 22, 2023
Tokyo Tech, Tohoku University, Fujitsu, and RIKEN start collaboration to develop distributed training of Large Language Models
Thursday, May 18, 2023
Fujitsu launches Biodrug Design Accelerator platform to accelerate peptide drug discovery research
富士通、ペプチド創薬の研究プロセスを管理するプラットフォーム「Biodrug Design Accelerator」を提供開始
Wednesday, May 17, 2023
京都大学・Chordia Therapeutics・富士通、因果関係を発見するAI技術を用いてがんの新薬に対するバイオマーカーを発見する実証実験を開始
Fujitsu, Kyoto University, and Chordia Therapeutics launch AI trials to discover biomarkers for new cancer drugs
Tuesday, May 16, 2023
Fujitsu successfully completes public takeover offer of GK Software
Friday, May 12, 2023
富士通、武田薬品、国立がん研究センターとの共同研究により、卵巣がん患者のペイシェントジャーニーを分析・可視化
Fujitsu conducts project with Takeda and National Cancer Center Japan to analyze and visualize of patient journey with ovarian cancer
Thursday, May 11, 2023
Fujitsu signs ETA with ServiceNow, boosting human resource development capabilities for ServiceNow business
富士通、AI技術を活用し、TOYOTA GAZOO Racingの世界耐久選手権におけるレース戦略立案を支援
Fujitsu Ltd Links

https://plus.google.com/+Fujitsu

https://www.facebook.com/FujitsuJapan

https://twitter.com/Fujitsu_Global

https://www.youtube.com/user/FujitsuOfficial

https://www.linkedin.com/company/fujitsu/

Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575